Heparin and protamine titration does not improve haemostasis after cardiac surgery: A prospective randomized study

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Radulovic, Vladimir ^a   Laffin, Anna ^a   Hansson, Kenny M ^b   Backlund, Erika ^a   Baghaei, Fariba ^a   Jeppsson, Anders ^a,c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; HEPARIN; PROTAMINE; THROMBIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A;

ACTIVATED CLOTTING TIME; AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOOD VOLUME; CALIBRATED AUTOMATED THROMBOGRAPHY; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG DOSE TITRATION; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEART SURGERY; HEART VALVE SURGERY; HEMOSTASIS; HEMOSTASIS TESTING SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOELASTOMETRY; ANNULOPLASTY; BLOOD CLOTTING TEST; BLOOD LOSS, SURGICAL; DOSE CALCULATION; DRUG ADMINISTRATION; DRUG EFFECTS; METABOLISM; MIDDLE AGED;

AGED; ANTICOAGULANTS; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; CARDIAC VALVE ANNULOPLASTY; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; DRUG DOSAGE CALCULATIONS; FACTOR XA; FEMALE; HEMOSTASIS; HEPARIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTAMINES; THROMBIN;

EID: 84940434894     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130271     Document Type: Article

References (31)

1. Bevan DH (1999) Cardiac bypass haemostasis: putting blood through the mill. Br J Haematol 104: 208-219. PMID: 10050700
2. Finley A, Greenberg C (2013) Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg 116: 1210-1222. doi: 10.1213/ANE.0b013e31827e4e62 PMID: 23408671
3. Gravlee GP, Brauer SD, Roy RC, Howard G, Kiger J, Scott C, et al. (1987) Predicting the pharmacodynamics of heparin: a clinical evaluation of the Hepcon System 4. J Cardiothorac Anesth 1: 379-387. PMID: 2979107
4. Aziz KA, Masood O, Hoschtitzky JA, Ronald A (2006) Does use of the Hepcon point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg 5: 469-482. PMID: 17670623
5. Dacey LJ, Munoz JJ, Baribeau YR, Johnson ER, Lahey SJ, Leavitt BJ, et al. (1998) Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg 133: 442-447. PMID: 9565127
6. Davidson SJ, Burman JF, Philips SM, Onis SJ, Kelleher AA, De Souza AC, et al. (2003) Correlation between thrombin potential and bleeding after cardiac surgery in adults. Blood Coagul Fibrinolys 14: 175-179.
7. Solomon C, Rahe-Meyer N, Sorensen B (2011) Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery. Thromb Res 128: 277-282. doi: 10.1016/j.thromres.2011.02.022 PMID: 21429567
8. Harker LA, Malpass TW, Branson HE, Hessel EA, Slichter SJ (1980) Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective alpha-granulae release. Blood 56: 824-834. PMID: 6448643
9. Radulovic V, Hyllner M, Ternstrom L, Karlsson M, Bylock A, Hansson KM, et al. (2012) Sustained heparin effect contributes to reduced plasma thrombin generation capacity early after cardiac surgery. Thromb Res 130: 769-774. doi: 10.1016/j.thromres.2011.12.025 PMID: 22261474
10. Schols SE, Lance MD, Feijge MA, Damoiseaux J, Marcus MA, Hamulyák K, et al. (2010) Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Thromb Haemost 103: 318-328. doi: 10.1160/TH09-06-0396 PMID: 20024495
11. Ogawa S, Szlam F, Chen EP, Nishimura T, Kim H, Roback JD, et al. (2012) A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 52: 14-22. doi: 10.1111/j.1537-2995.2011.03241.x PMID: 21756263
12. Wong RK, Sleep JR, Visner AJ, Raasch DJ, Lanza LA, DeValeria PA, et al. (2011) Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate haemostasis. J Extra Corpor Technol 43: 19-25. PMID: 21449230
13. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, et al. (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32: 249-253. PMID: 13679651
14. Coakley M, Hall JE, Evans C, Duff E, Billing V, Yang L, et al. (2011) Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding. J Thromb Haemost 9: 282-292. doi: 10.1111/j.1538-7836.2010.04146.x PMID: 21091865
15. Tanaka KA, Thourani VH, Williams WH, Duke PG, Levy JH, Guyton RA, et al. (2007) Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. J Anesth 21:97-303.
16. Mittermayr M, Margreiter J, Velik-Salchner C, Klinger A, Streif W, Fries D, et al. (2005) Effects of protamine and heparin can be detected and easily differentiated by modified thromboelastography (Rotem): an in vitro study. Br J Anaesth 95: 310-316. PMID: 16024582
17. Luddington RJ (2005) Thrombelastography/thromboelastometry. Clin Lab Haematol. 27: 81-90. PMID: 15784122
18. Hofmann B, Bushnaq H, Kraus F, Raspé C, Simm A, Silber RE, et al. (2013) Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy. Perfusion 28: 412-418. doi: 10.1177/0267659113483800 PMID: 23625867
19. Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, et al. (2002) Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 97: 837-841. PMID: 12357148
20. Hemker HC, Beguin S (2013) Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a rebuttal. J Thromb Haemost 11: 564. doi: 10.1111/jth.12116 PMID: 23289967
21. Buyue Y, Misenheimer TM, Sheehan JP (2013) Low-molecular-weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a reply to rebuttal. J Thromb Haemost 11: 565-566. doi: 10.1111/jth.12136 PMID: 23332108
22. Buyue Y, Misenheimer TM, Sheehan JP (2012) Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism. J Thromb Haemost 10: 2086-2098. doi: 10.1111/j.1538-7836.2012.04892.x PMID: 22905983
23. Wang J, Ma HP, Zheng H (2013) Blood loss after cardiopulmonary bypass, standard vs titrated protamine: A meta-analysis. Neth J Med 71: 123-127. PMID: 23712807
24. Koster A, Borgermann J, Gummert J, Rudloff M, Zittermann A, Schirmer U (2013) Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: Results of a randomized double-blind controlled pilot study. Clin App Thromb Hemost 20: 290-295.
25. Galeone A, Rotunno C, Guida P, Assunta B, Rubino G, Schinosa Lde L, et al. (2013) Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth 27: 853-858. doi: 10.1053/j.jvca.2012.10.020 PMID: 23627997
26. Despotis GJ, Joist JH, Hogue CW Jr., Alsoufiev A, Kater K, Goodnough LT, et al. (1995) The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 110: 46-54. PMID: 7609568
27. Newsome J, Stipanovich K, Flaherty S (2004) Comparison of heparin administration using the Rapidpoint Coag and Hepcon HMS. J Extra Corpor Technol 36: 139-144. PMID: 15334753
28. Ichikawa J, Kodaka M, Nishiyama K, Harasaki Y, Ozaki M, Komori M (2014) Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 28: 1015-1019. doi: 10.1053/j.jvca.2013.10.010 PMID: 24508375
29. Taneja R, Berry L, Pappu U, Stitt L, Sayal P, Allen P, et al. (2014) Protamine requirements in cardiac surgery: effect of changes in the heparin reference standard. J Cardiothorac Vasc Anesth 28: 1227-1232. doi: 10.1053/j.jvca.2014.04.024 PMID: 25281041
30. van Veen JJ, Gatt A, Cooper PC, Kitchen S, Bowyer AE, Makris M (2008) Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagul Fibrinolys 19: 183-189.
31. Said R, Regnault V, Hacquard M, Carteaux JP, Lecompte T (2012) Platelet-dependent thrombography gives a distinct pattern of in vitro thrombin generation after surgery with cardio-pulmonary bypass: potential implications. Thromb J 10:15. doi: 10.1186/1477-9560-10-15 PMID: 22909275